New pill could help regrow hair in alopecia areata patients
Disease control
Recruiting now
This study tests an experimental oral drug called NXC736 in 73 adults with moderate to severe alopecia areata, a condition causing patchy or total hair loss. Participants are randomly assigned to receive either NXC736 or a placebo for 12 weeks. The main goal is to see if the drug…
Phase: PHASE2 • Sponsor: NEXTGEN Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC